Irinotecan Combined With Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer : a Single Center Prospective Clinical Trial

Clinical trial NCT01051765 · UNKNOWN

Trial details

NCT number: NCT01051765
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Esophageal Squamous Carcinoma

Start date: 2009-08-01
Primary completion: 2011-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.